Fidson, led by Fidelis Ayebae, declares $1.49 million dividend for shareholders
The payout reflects the pharmaceutical group’s focus on rewarding investors following an impressive financial performance in 2024.
Fidson Healthcare
Nigerian pharma tycoon Fidelis Ayebae’s Fidson posts $3.41 million profit in 2024
This growth was driven by a surge in sales of ethical and OTC products, reinforcing Fidson’s position as a top player in Nigeria’s pharmaceutical industry.
Fidelis Ayebae’s stake in Fidson Healthcare falls to under $7 million
Fidson Healthcare founder, Fidelis Ayebae, sees major stake decline, but holds firm in pharma industry.
Nigerian pharma tycoon Fidelis Ayebae's Fidson receives support to expand production capacity
The collaboration with NEXIM is expected to position Fidson for a stronger presence in Africa's rapidly expanding pharmaceutical market.
Fidson, owned by Fidelis Ayebae, plans $100-million medicine production plant in Lekki FTZ
This move aligns with the company’s efforts to bolster Nigeria’s self-sufficiency in healthcare, focusing on combating the country's ongoing HIV crisis.
Fidson, owned by Nigerian tycoon Fidelis Ayebae, strikes deal to establish pharmaceutical plant
The deal is part of a broader initiative to enhance self-sufficiency in Africa’s healthcare infrastructure, particularly in the battle against HIV.
Fidson healthcare to raise $12.9 million as Nigerian tycoon Fidelis Ayebae seeks shareholder approval
Fidson Healthcare Plc, a leading Nigerian pharmaceutical manufacturing company led by Fidelis Ayebae, will seek shareholders’ approval to raise additional capital of up to N20 billion at its forthcoming 25th Annual General Meeting.
Nigerian tycoon Fidelis Ayebae’s Fidson achieves revenue exceeding $37 million in 2023
The surge in revenue is linked to the heightened sales of ethical products, including infusions, capsules, and tablets.
Nigerian tycoon Fidelis Ayebae gains $1.1 million from Fidson stake
Ayebae, a banker turned accomplished industrialist, owns a 33.1-percent stake in the pharmaceutical company, which translates to 759,643,749 ordinary shares.
Nigerian tycoon Fidelis Ayebae gains $1.4 million from investment in Fidson
The recent gains solidify Ayebae’s position as one of Africa’s pharmaceutical industry magnates.
Nigerian tycoon Fidelis Ayebae loses over $1 million from Fidson stake
Ayebae owns an impressive 33.1-percent stake in Fidson Healthcare.
Nigerian pharma tycoon Fidelis Ayebae’s Fidson smashes expectations with $9.08-million profit
Fidson Healthcare has established itself as a leading player in the Nigerian and West African pharmaceutical industries.